IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
Go back to IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 5.41 +0.16 (3.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.25 | 52 Week High | $0.04 | |||
| Open | $5.31 | 52 Week Low | $0.00 | |||
| Day High | $5.43 | P/E | N/A | |||
| Day Low | $5.30 | EPS | $-0.09 | |||
| Volume | 122,594 | |||||
